JAK1 and systemic lupus erythematosus: In patients with SLE, aberrant activation of IFN-I signaling, such as increased expression of STAT1, constitutive phosphorylation of JAK1 and STAT2, and an exaggerated response to IFN-β stimulation in immune cells, can be readily observed (10).